Gongwin Biopharm Holdings Co (ROCO:6617) Total Stockholders Equity : NT$2,961.57 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Gongwin Biopharm Holdings Co Total Stockholders Equity?

Gongwin Biopharm Holdings Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$2,961.57 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Gongwin Biopharm Holdings Co's Book Value per Share for the quarter that ended in Mar. 2025 was NT$23.77. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Gongwin Biopharm Holdings Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.04.

Gongwin Biopharm Holdings Co Total Stockholders Equity Historical Data

The historical data trend for Gongwin Biopharm Holdings Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gongwin Biopharm Holdings Co Total Stockholders Equity Chart

Gongwin Biopharm Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

1,093.06

970.72

1,391.80

1,315.49

3,106.55

Gongwin Biopharm Holdings Co Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,326.98	3,314.84	3,190.54	3,106.55	2,961.57

Gongwin Biopharm Holdings Co (ROCO:6617) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Gongwin Biopharm Holdings Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2961.574	-	0)	/	124.616
	=	23.77

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Gongwin Biopharm Holdings Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(118.336	+	12.253)	/	2961.574
	=	0.04

Gongwin Biopharm Holdings Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Gongwin Biopharm Holdings Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gongwin Biopharm Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gongwin Biopharm Holdings Co Ltd (ROCO:6617) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, No.80, Jianguo North Road, Section 1, Zongshan District, Taipei, TWN, 10491

Website

http://www.gongwinbiopharm.com

Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.

Gongwin Biopharm Holdings Co Headlines

No Headlines